
Bright bloom
Semax, an ACTH-derived peptide investigated in preclinical studies of neurotrophic signaling, neuronal pathways, and neurobiology.
NASAL SPRAYS
Compound formulations associated with neurotrophic, neurotransmitter, and neuroendocrine research.

Semax, an ACTH-derived peptide investigated in preclinical studies of neurotrophic signaling, neuronal pathways, and neurobiology.

Selank, a tuftsin-derived peptide investigated in studies of neurotransmitter signaling, stress-response pathways, and neuroimmune interactions.

DSIP, a peptide investigated in experimental studies of sleep-related physiology and neuroendocrine signaling. Evidence remains limited.

A Semax and Selank research blend. The individual compounds have been investigated in neurotrophic, neurotransmitter, and neuroimmune signaling studies; those findings do not establish effects of this blend.

A Selank and DSIP research blend. The individual compounds have been investigated in neuroendocrine and stress-response studies; evidence for the combined formulation is not established.

PT-141 research nasal spray associated with studies of melanocortin receptor activity and central neuroendocrine signaling.
EMBER BLOOM™ · PT-141
Ember Bloom™ contains PT-141, a compound investigated in published research on melanocortin receptor activity and central neuroendocrine signaling.